Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butoconazole nitrate vaginal suppository versus miconazole nitrate vaginal capsules for vulvovaginal candidiasis
ChiCTR-TRC-10001039Phase 2Completed
- Sponsor
- West China Second University Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of butoconazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Clinical efficacy after treatment at 7-14 days, Etiological efficacy after treatment at 7-14 days and 4 more. Started Apr 2009; status: completed.
02
Drugs
butoconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on ChiCTR-TRC-10001039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001039.